Last reviewed · How we verify
NCT06861010
Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Phase 3 trial testing Placebo in Pancreatic Diseases in 44 participants. Currently enrolling.
20 December 2026
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | Phase 3 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 1 March 2025 |
| Primary completion | 20 December 2026 |
| Estimated completion | 20 December 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Placebo
- Ondansetron (ondansetron) — full drug profile →
Conditions studied
- Pancreatic Diseases — all drugs for Pancreatic Diseases →
Sponsor
Tanta University
Who can join
Adults 18 to 65, any sex, with Pancreatic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Endoscopic retrograde cholangiopancreatography (ERCP (, a key tool that is used in diagnosis and treatment of pancreato-biliary diseases. Post-ERCP pancreatitis (PEP) is the most common and serious complication that can occur following this procedure and can lead to significant morbidity and mortality. A variety of patient-related and procedure-related factors have been associated with higher rates of PEP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06861010
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ondansetron
Trials testing the same drug.
- NCT07310563 — A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obe · Phase 1 · completed
- NCT06898268 — Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux · NA · completed
- NCT06475846 — A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults · Phase 2 · completed
- NCT06390787 — The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics · Phase 2, PHASE3 · completed
- NCT06428084 — Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONV · Phase 2 · completed
Other recruiting trials for Pancreatic Diseases
Currently open trials in the same condition.
- NCT06790134 — Validation of an AI-Assisted Pancreatic EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Tri · NA · recruiting
- NCT07030348 — Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study · recruiting
- NCT06041009 — Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations · recruiting
- NCT04493632 — OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. · recruiting
- NCT05014347 — Patient Reported Experience in Endoscopic Ultrasound · active not recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06861010 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06861010.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing